- Category
- Medium (2023-24)
- Udyam number
- UDYAM-UP-28-0039039

About Dr Willmar Schwabe India Private Limited
Data last updated:
Dr Willmar Schwabe India Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Schwabe International Se, Germany. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 March 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PTC057707. Its GSTIN is 07AAACD0463D2Z7 (Delhi). The company holds 12 GST registrations, of which 9 are active.
The company has an authorised share capital of ₹185 Cr and a paid-up capital of ₹19.13 Cr. It is led by directors including Ashish Kumar (Managing Director) and Dr Anke Herta Balzer.
Its last annual general meeting (AGM) was held on 25 June 2025, and its latest financial statements are for the year ended 31 December 2024. The registered office is at H – 36 Green Park Extension, New Delhi, Delhi, India – 110016.
As per the financials filed for FY 2022, the company reported a revenue of ₹284.52 Cr, a growth of 10% compared to the previous year. Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 19% over five years.
The company has about 814 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Schwabe India and Sanat Products. As per MCA filings, the company has satisfied charges of ₹3.6 Cr on record. Court records list 46 cases involving the company, including 27 filed by the company and 19 filed against it; 12 cases are pending. The company has 2 deals on record (2 secondary share transfers); the latest was in March 2017. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Gracure Pharmaceuticals Limited with revenue of ₹287.44 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2023, listing 737 overdue payments to 73 micro and small suppliers.
Dr Willmar Schwabe India Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0039039). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website schwabeindia.com.
Company details
Recognitions & Rankings of Dr Willmar Schwabe India
Contact details
Dr Willmar Schwabe India Private Limited's registered office is in New Delhi, Delhi. Its website is schwabeindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Apps
- Registered AddressH – 36 Green Park Extension, New Delhi, Delhi, India – 110016
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dr Willmar Schwabe India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Dr Willmar Schwabe India operates two associated brands: Schwabe India and Sanat Products. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Homeopathic medicine manufacturing and online retail in India. | schwabeindia.com | |
| Herbal extracts and pharmaceutical products manufacturing in India. | hindustanherbals.org |
Financials of Dr Willmar Schwabe India Private Limited
FY 2024 filings availableDr Willmar Schwabe India Private Limited reported revenue of ₹284.52 Cr (up 10% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 10% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr Willmar Schwabe India Private Limited, buy the company report.
Board of directors of Dr Willmar Schwabe India Private Limited
Dr Willmar Schwabe India has 7 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akhilesh Kumar Tripathi | Alternate Director | 11 Dec 2025 | 0 Years 11 Months | Current |
| Ashish Kumar | Managing Director | 07 Nov 2011 | 15 Years 0 Months | Current |
| Dr Anke Herta Balzer | Director | 01 Oct 2019 | 7 Years 1 Months | Current |
| Dr Frank Waimer | Director | 01 Feb 2024 | 2 Years 9 Months | Current |
| Joachim August Thole | Director | 01 Feb 2024 | 2 Years 9 Months | Current |
| Patrick Krauth | Director | 01 Feb 2005 | 21 Years 9 Months | Current |
Peer comparison
Dr Willmar Schwabe India Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gracure Pharmaceuticals Limited | ₹287.44 Cr (FY 2025) | 27.0% | New Delhi, Delhi, India | |||
| Pinnacle Life Science Private Limited | ₹286.72 Cr (FY 2023) | -2.0% | Baddi, Himachal Pradesh, India | |||
| Sava Healthcare Limited | ₹284.97 Cr (FY 2025) | 14.0% | Wadhwan, Gujarat, India | |||
| Med Manor Organics Private Limited | ₹284.93 Cr (FY 2025) | 5.0% | Hyderabad, Telangana, India | |||
| Dr Willmar Schwabe India Private Limitedthis company | ₹284.52 Cr (FY 2022) | 10.0% | 814 | New Delhi, Delhi, India | ||
| Amanta Healthcare Limited | ₹276.09 Cr (FY 2025) | -2.0% | Ahmedabad, Gujarat, India | |||
| Amn Life Science Private Limited | ₹273.11 Cr (FY 2025) | 42.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Dr Willmar Schwabe India Private Limited, buy the company report.
Auditor
Dr Willmar Schwabe India Private Limited is audited by Deepak K Kejrewal & Co. for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deepak K Kejrewal & Co. | FY 2021 | 011919N |
Shareholding
The shareholding of Dr Willmar Schwabe India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dr Willmar Schwabe India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Mar 1999 | 90053539 | Dresdner Bank Ag | ₹- | Satisfied | |
| 29 Jan 1998 | 90053250 | Deutsche Bank | ₹3.6 Cr | Satisfied |
To see the full charge records of Dr Willmar Schwabe India Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Dr Willmar Schwabe India Private Limited has 2 deals on record (2 secondary share transfers); the latest was in March 2017.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Secondary share transfer | Undisclosed | Seller: Schwabe International Gmbh |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: Schwabe International Gmbh Seller: Kamlesh Gupta Huf, R K Imports Private Limited, Homeopathic Distributers Limited, an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Dr Willmar Schwabe India Private Limited has 46 court cases on record: 27 filed by Dr Willmar Schwabe India, 19 filed against it. 12 cases are pending and 34 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 29 | 8 | 11 |
| High courts | 17 | 11 | 1 |
Cases on record (5 of 46)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against Ms Vortax Multitrade India LLP | Pending |
| District court, Gautam Buddha Nagar, Uttar Pradesh | Civil suit | Filed against the company by M/S Hill Natural Extract LLP | Pending |
| High Court, UTTARPRADESH | Court case (A227) | Filed by the company against M/S Hill Natural Extract LLP and 5 Others | Pending |
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed by the company against Hill Natural Extract LLP and Ors. | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Dr Willmar Schwabe India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Dr Willmar Schwabe India Private Limited has 14 MSME Form 1 returns on record between 2019 and 2023, listing 737 overdue payments to 73 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 73)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bacfo Pharmaceuticals (India ) Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Aar Reprographics | |||
| Biogenix Systems Private Limited |
To see the full MSME payment records of Dr Willmar Schwabe India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Dr Willmar Schwabe India Private Limited has a workforce of 814 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 814 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 | |
| FY 2014-15 | |
| FY 2013-14 | |
| FY 2012-13 |
To see the full employee and EPFO history of Dr Willmar Schwabe India Private Limited, buy the company report.
GST
Dr Willmar Schwabe India has 12 GST registrations: 9 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACD0463D2Z7 | Delhi | Active | 04 Oct 2021 |
| 09AAACD0463D1Z4 | Uttar Pradesh | Active | 01 Jul 2017 |
| 10AAACD0463D1ZL | Bihar | Active | 01 Jul 2017 |
| 19AAACD0463D1Z3 | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dr Willmar Schwabe India Private Limited, buy the company report.
Recent activity
Dr Willmar Schwabe India Private Limited has 16 board changes on record since 2005: 7 appointments and 9 cessations. The latest: Akhilesh Kumar Tripathi was appointed as Alternate Director on 11 Dec 2025.
12 earlier events are in the company report.
News
Frequently asked questions
Dr Willmar Schwabe India is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 March 1994 (32+ years old) and is registered under CIN U74899DL1994PTC057707.
Dr Willmar Schwabe India has 7 current directors:
- Ashish Kumar - Managing Director
- Akhilesh Kumar Tripathi - Alternate Director
- Dr Anke Herta Balzer - Director
- Dr Frank Waimer - Director
- Joachim August Thole - Director
- Patrick Krauth - Director
- Vikram Grover - Alternate Director
The latest financial statements of Dr Willmar Schwabe India on record with the MCA are for the year ended 31 December 2024. Its last annual general meeting was held on 25 June 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dr Willmar Schwabe India is 07AAACD0463D2Z7, registered in Delhi. The company has 12 GST registrations in all, of which 9 are active and 3 are cancelled or inactive. Other active GSTINs include 09AAACD0463D1Z4 (Uttar Pradesh), 10AAACD0463D1ZL (Bihar), 19AAACD0463D1Z3 (West Bengal).
The CIN (Corporate Identification Number) of Dr Willmar Schwabe India is U74899DL1994PTC057707. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr Willmar Schwabe India has 46 court cases on record: 27 filed by the company and 19 filed against it. 12 are pending. Most are in the district courts.
Dr Willmar Schwabe India was incorporated on 04 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
Dr Willmar Schwabe India has 2 deals on record (2 secondary share transfers); the latest was in March 2017.
The peers of Dr Willmar Schwabe India by revenue are Gracure Pharmaceuticals Limited, Pinnacle Life Science Private Limited, Sava Healthcare Limited, Med Manor Organics Private Limited, Amanta Healthcare Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Akhilesh Kumar Tripathi was appointed as Alternate Director on 11 Dec 2025. Vikram Grover was appointed as Alternate Director on 11 Dec 2025. Dr Frank Waimer was appointed as Director on 01 Feb 2024. Dr Willmar Schwabe India has 16 board changes on record in total.
Yes, Dr Willmar Schwabe India is registered as a medium enterprise under Udyam registration (number: UDYAM-UP-28-0039039).
Dr Willmar Schwabe India has 14 MSME Form 1 returns on record between 2019 and 2023, listing 737 overdue payments to 73 micro and small suppliers. The latest return was filed on 02 Mar 2024.

